These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7761697)

  • 1. Growth hormone responses to growth hormone-releasing hormone and clonidine in dogs with Cushing's syndrome.
    Regnier A; Garnier F
    Res Vet Sci; 1995 Mar; 58(2):169-73. PubMed ID: 7761697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
    Leal-Cerro A; Soto A; Martínez MA; Alvarez P; Isidro L; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing's syndrome.
    Leal-Cerro A; Pumar A; Villamil F; Astorga R; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):399-403. PubMed ID: 8319372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
    Leal-Cerro A; Pumar A; Garcia-Garcia E; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):649-54. PubMed ID: 7828354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridostigmine enhances even if it does not normalize the growth hormone responses to growth hormone-releasing hormone in patients with Cushing's disease.
    Giustina A; Bossoni S; Bodini C; Ferrari C; Pizzocolo G; Scalvini T; Schettino M; Wehrenberg WB
    Horm Res; 1991; 35(3-4):99-103. PubMed ID: 1806475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on growth hormone (GH) responses to GH-releasing hormone in patients with Cushing's syndrome.
    Leal-Cerro A; Pereira JL; Garcia-Luna PP; Astorga R; Cordido F; Casanueva FF; Dieguez C
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):291-5. PubMed ID: 2225484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease.
    Giustina A; Bossoni S; Bussi AR; Pozzi A; Wehrenberg WB
    Endocr Res; 1993 Mar; 19(1):47-56. PubMed ID: 7681769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome.
    Leal-Cerro A; Venegas E; Garcia-Pesquera F; Jimenez LM; Astorga R; Casanueva FF; Dieguez C
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):117-21. PubMed ID: 9509077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of growth hormone-releasing hormone (GHRH) and clonidine in stimulating GH release in young and old dogs.
    Arce V; Cella SG; Loche S; Ghigo E; Devesa J; Müller EE
    Brain Res; 1990 Dec; 537(1-2):359-62. PubMed ID: 2085787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of impaired growth hormone secretion in patients with Cushing's disease.
    Takahashi H; Bando H; Zhang C; Yamasaki R; Saito S
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):13-7. PubMed ID: 1519417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
    Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
    Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pharmacological reduction of plasma free fatty acids enhances the growth hormone (GH)-releasing hormone-mediated GH secretion in patients with Cushing's syndrome.
    Leal-Cerro A; Jimenez LM; Astorga R; Fernandez-Lopez I; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3165-8. PubMed ID: 9284763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man.
    Burguera B; Muruais C; Peñalva A; Dieguez C; Casanueva FF
    Neuroendocrinology; 1990 Jan; 51(1):51-8. PubMed ID: 2106087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy.
    Giustina A; Buffoli MG; Bussi AR; Doga M; Girelli A; Pizzocolo G; Pozzi A; Wehrenberg WB
    Horm Metab Res; 1992 May; 24(5):240-3. PubMed ID: 1398465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep.
    Magnan E; Cataldi M; Guillaume V; Mazzocchi L; Dutour A; Razafindraibe H; Sauze N; Renard M; Oliver C
    Endocrinology; 1994 Feb; 134(2):562-7. PubMed ID: 7905408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.
    Leal-Cerro A; Torres E; Soto A; Dios E; Deghenghi R; Arvat E; Ghigo E; Dieguez C; Casanueva FF
    Neuroendocrinology; 2002 Dec; 76(6):390-6. PubMed ID: 12566947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined administration of growth-hormone-releasing hormone and clonidine restores defective growth hormone secretion in old dogs.
    Cella SG; Arce VM; Pieretti F; Locatelli V; Settembrini BP; Müller EE
    Neuroendocrinology; 1993 Mar; 57(3):432-8. PubMed ID: 8321415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of human growth hormone-releasing hormone on GH secretion in Cushing's syndrome and non-endocrine disease patients treated with glucocorticoids.
    Hotta M; Shibasaki T; Masuda A; Imaki T; Sugino N; Demura H; Ling N; Shizume K
    Life Sci; 1988; 42(9):979-84. PubMed ID: 3125399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.